SNRPCP13

Across TCGA pan-cancer cohorts, SNRPCP13 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of SNRPCP13’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where SNRPCP13 RNA is repressed in tumor relative to normal tissue. In most cancer types SNRPCP13 is over-expressed in tumor, although a few such as LUSC and THCA show the opposite, repressed pattern.

LUSC, THCA, and STAD are the cancer types where SNRPCP13 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SNRPCP13 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	Female	All	−0.382	<.001	6	view →
THCA	Male	IV	−0.366	<.001	3	view →
STAD	All	All	+0.360	.016	2	view →
UCEC	All	All	−0.349	.016	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

SNRPCP13–LUSC

Open the LUSC breakdown →